
TY  - JOUR
TI  - POSTER SESSION 1, SUNDAY 24 AUGUST
JO  - European Journal of Neurology
VL  - 15
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2008.02285.x
DO  - doi:10.1111/j.1468-1331.2008.02285.x
SP  - 32
EP  - 220
PY  - 2008
ER  - 

TY  - JOUR
AU  - Pipkin, M.F.
AU  - Lockridge, R.S.
AU  - Spencer, M.O.
AU  - Craft, V.W.
AU  - Campbell, D.L.
TI  - 6 Month Experience with 1 Nurse Training 2 Patients Together for Nightly Home Hemodialysis
JO  - Hemodialysis International
VL  - 8
IS  - 1
SN  - 1492-7535
UR  - https://doi.org/10.1111/j.1492-7535.2004.0085bn.x
DO  - doi:10.1111/j.1492-7535.2004.0085bn.x
SP  - 103
EP  - 103
PY  - 2004
AB  - Objective:? To have 1 nurse successfully train 2 patients at a time for nightly home hemodialysis (NHHD) within a 7?10 week time period. Methods:? Over the past 6 years, Lynchburg Nephrology Dialysis Inc. has evolved its NHHD program from 1 nurse training 1 patient during an average 6 week period to training 2 patients in a 7?10 week period. Patients came either from our in-center population or directly from internal medicine. Our pre-evaluation procedures and manual were revised. Patients were pre-evaluated for literacy, manual dexterity, strength, hearing and visual deficits, substance abuse, psychiatric disorders, and compliance before being accepted into the program. A home visit was made to evaluate their environment, family interactions, and water source. Our training manual was rewritten to fifth grade level. Every patient was given index cards printed in 20 size font with step-by-step procedures for machine setup, put-on and takeoff, re-circulation, and power failure. Patients were dialyzed 4 days/week to improve cognitive function and ?dialyzed the bucket? 1 day, thus training 5 days/week. One nurse trained 2 patients, staggering their start dates 2 weeks apart to allow for both individual and group teaching. Fistula or IJ catheter was used for access. Patients were trained alone or with a partner. In the last week of training, patients were dialyzed for 7?h and were expected to complete all procedures independently. Results:? From March 2003 to August 2003, 6 patients were trained for NHHD. 2 patients finished training in 7 weeks, 2 in 9 weeks, and 2 in 10 weeks. Conclusion:? One nurse can successfully train 2 patients at a time for NHHD in a 7?10 week time period at a decreased cost to dialysis provider.
ER  - 

TY  - JOUR
TI  - Posters Group 1 - Immunology
JO  - Allergy
VL  - 56
IS  - S68
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2001.tb05137.x
DO  - doi:10.1111/j.1398-9995.2001.tb05137.x
SP  - 108
EP  - 145
PY  - 2001
ER  - 

TY  - JOUR
TI  - Research Competitions (Oral Presentations) (Abstracts 1 to 18)
JO  - Clinical Oral Implants Research
VL  - 20
IS  - 9
SN  - 0905-7161
UR  - https://doi.org/10.1111/j.1600-0501.2009.01804.x
DO  - doi:10.1111/j.1600-0501.2009.01804.x
SP  - 858
EP  - 1047
PY  - 2009
ER  - 

TY  - JOUR
TI  - Oral Sessions 1-9
JO  - Transplant International
VL  - 18
IS  - s1
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2005.18s1_001.x
DO  - doi:10.1111/j.1432-2277.2005.18s1_001.x
SP  - 2
EP  - 17
PY  - 2005
ER  - 

TY  - JOUR
TI  - Educational Session 1: Blood Banking
JO  - Vox Sanguinis
VL  - 93
IS  - s2
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2007.00986.x
DO  - doi:10.1111/j.1423-0410.2007.00986.x
SP  - 1
EP  - 41
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 13 September
JO  - European Journal of Neurology
VL  - 16
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2009.02821.x
DO  - doi:10.1111/j.1468-1331.2009.02821.x
SP  - 55
EP  - 334
PY  - 2009
ER  - 

TY  - JOUR
TI  - Basic science/optical diagnostics
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 39
IS  - S19
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.20495
DO  - doi:10.1002/lsm.20495
SP  - 1
EP  - 14
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts 1–204
JO  - Hepatology
JA  - Hepatology
VL  - 50
IS  - S4
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.23300
DO  - doi:10.1002/hep.23300
SP  - 302A
EP  - 401A
PY  - 2009
ER  - 

TY  - JOUR
TI  - Section 1: Main Scientific Program: Invited Speakers
JO  - Pain Practice
JA  - Pain Pract
VL  - 14
IS  - s1
SN  - 1530-7085
UR  - https://doi.org/10.1111/papr.12201
DO  - doi:10.1111/papr.12201
SP  - 1
EP  - 133
PY  - 2014
ER  - 

TY  - JOUR
TI  - ICS abstracts 1–12
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodyn.
VL  - 21
IS  - 4
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.17
DO  - doi:10.1002/nau.17
SP  - 284
EP  - 300
PY  - 2002
ER  - 

TY  - JOUR
TI  - Invited speakers (Abstracts 1 to 26)
JO  - Clinical Oral Implants Research
VL  - 15
IS  - 4
SN  - 0905-7161
UR  - https://doi.org/10.1111/j.1600-0501.2004.t01-26-bmv_1.x
DO  - doi:10.1111/j.1600-0501.2004.t01-26-bmv_1.x
SP  - xxiii
EP  - lxxxviii
PY  - 2004
ER  - 

TY  - JOUR
AU  - Song, Shang
AU  - Roy, Shuvo
TI  - Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices
JO  - Biotechnology and Bioengineering
JA  - Biotechnol. Bioeng.
VL  - 113
IS  - 7
SN  - 0006-3592
UR  - https://doi.org/10.1002/bit.25895
DO  - doi:10.1002/bit.25895
SP  - 1381
EP  - 1402
KW  - type 1 diabetes (T1D)
KW  - islet encapsulation
KW  - macroencapsulation devices
KW  - immunoisolation
KW  - cells and biomaterials
KW  - micro-electro-mechanical systems (MEMS)
PY  - 2016
AB  - ABSTRACT Macroencapsulation technology has been an attractive topic in the field of treatment for Type 1 diabetes due to mechanical stability, versatility, and retrievability of the macro-capsule design. Macro-capsules can be categorized into extravascular and intravascular devices, in which solute transport relies either on diffusion or convection, respectively. Failure of macroencapsulation strategies can be due to limited regenerative capacity of the encased insulin-producing cells, sub-optimal performance of encapsulation biomaterials, insufficient immunoisolation, excessive blood thrombosis for vascular perfusion devices, and inadequate modes of mass transfer to support cell viability and function. However, significant technical advancements have been achieved in macroencapsulation technology, namely reducing diffusion distance for oxygen and nutrients, using pro-angiogenic factors to increase vascularization for islet engraftment, and optimizing membrane permeability and selectivity to prevent immune attacks from host's body. This review presents an overview of existing macroencapsulation devices and discusses the advances based on tissue-engineering approaches that will stimulate future research and development of macroencapsulation technology. Biotechnol. Bioeng. 2016;113: 1381?1402. ? 2015 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 9 September
JO  - European Journal of Neurology
VL  - 19
IS  - s1
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2012.03888.x
DO  - doi:10.1111/j.1468-1331.2012.03888.x
SP  - 90
EP  - 457
PY  - 2012
ER  - 

TY  - JOUR
TI  - COPD SIG 1
JO  - Respirology
VL  - 14
IS  - s1
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2009.01503_5.x
DO  - doi:10.1111/j.1440-1843.2009.01503_5.x
SP  - A51
EP  - A54
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts 1 to 257
JO  - Hepatology
JA  - Hepatology
VL  - 42
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.20923
DO  - doi:10.1002/hep.20923
SP  - 196A
EP  - 298A
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.93_4
DO  - doi:10.1002/ejhf.93_4
SP  - 19
EP  - 98
PY  - 2014
ER  - 

TY  - JOUR
TI  - Numbered abstracts 1–283
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 8
IS  - S2
SN  - 1053-8569
UR  - https://doi.org/10.1002/(SICI)1099-1557(199908)8:2+<S79::AID-PDS429>3.0.CO;2-2
DO  - doi:10.1002/(SICI)1099-1557(199908)8:2+<S79::AID-PDS429>3.0.CO;2-2
SP  - S79
EP  - S188
PY  - 1999
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - Developmental Medicine & Child Neurology
JA  - Dev Med Child Neurol
VL  - 55
IS  - s2
SN  - 0012-1622
UR  - https://doi.org/10.1111/dmcn.12259
DO  - doi:10.1111/dmcn.12259
SP  - 26
EP  - 59
PY  - 2013
ER  - 

TY  - JOUR
TI  - 08. Surgery-8
JO  - Journal of Gastroenterology and Hepatology
VL  - 24
IS  - s1
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2009.06083_8.x
DO  - doi:10.1111/j.1440-1746.2009.06083_8.x
SP  - A205
EP  - A207
PY  - 2009
ER  - 
